我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

肾动脉射频消融对远期高血压及心脏重构的影响

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2015年第4期
页码:
451-455
栏目:
临床研究
出版日期:
2015-04-20

文章信息/Info

Title:
Effects of renal sympathetic denervation on long-term hypertension and cardiac remodeling in rabbits
作者:
于 亮1; 尚福军1; 王捷频; 欧东波1; 郑强荪1
(第四军医大学唐都医院：1.心内科，2.药剂科，陕西 西安 710038)
Author(s):
YU Liang1;  SHANG Fu-jun1;  WANG Jie-pin2;  OU Dong-bo1;  ZHENG Qiang-sun1
(1.Department of Cardiology, 2.Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi’an 710038, Shaanxi, China)
关键词:
高血压; 压力负荷性; 肾交感神经射频消融; 去甲肾上腺素; 血管加压素; 心脏重构
Keywords:
pressure-overload hypertension;  renal sympathetic denervation;  norepinephrine;  arginine vasopressin;  cardiac remodeling
分类号:
R544.1
DOI:
-
文献标识码:
A
摘要:
目的 观察肾动脉射频消融（renal sympathetic denervation，RSD）对远期高血压以及心脏重构的影响。方法 采用腹主动脉缩窄建立压力负荷性高血压兔模型，建模2个月进行RSD，术后2个月测定血压、左室质量指数（LVMI）、心肌胶原容积分数，以及血浆中去甲肾上腺素(NE)、精氨酸血管加压素(AVP)、血管紧张素Ⅱ(AngⅡ)、醛固酮(Ald)的变化。结果 RSD 2个月后，高血压+射频组的血压低于高血压组（P<0.05）。与假手术组比较，高血压组左室后壁厚度（LVPWT）、室间隔厚度（IVST）、LVMI明显增加（P<0.05），与高血压组比较，高血压+射频组上述数值明显下降（P<0.05）。心肌胶原容积分数（CVF）在高血压组是升高的，经消融后也得以降低（P<0.05）。高血压组NE、AngⅡ、Ald和AVP较假手术组明显升高（P<0.05），RSD后NE、AVP较高血压组明显下降（P<0.05），但Ald、AngⅡ无显著差异。结论 RSD可以降低压力负荷导致的血压升高，降低了心脏的肥厚程度和心肌纤维化。
Abstract:
AIM To observe the effects of renal sympathetic denervation (RSD) on long-term hypertension and cardiac remodeling. METHODS We established rabbit models of pressure overload hypertension by abdominal aortic constriction. After 2 months, abdominal RSD was carried out with radiofrequency ablation catheter. Two months after RSD, blood pressure values were measured by carotid artery intubation. For evaluation of the cardiac remodeling, left ventricular myocardial index was measured by weighing and calculating, ventricular wall thickness was measured by cardiac uhrasonography and myocardial fibrosis index was measured by Sirius scarlet staining method. Changes of NE, AVP, Ang II and Ald were also detected by ELISA. RESULTS Two months after RSD, blood pressure in hypertension+ablation group was lower than in hypertension group (P<0.05), but no significant difference was observed between control+ablation group and control group. Left ventricular posterior wall thickness (LVPWT), interventricular septum thickness (IVST) and left ventricular mass index (LVMI) increased significantly in hypertension group and control group (P<0.05). However, these values declined after ablation. Measurement of collagen content found that myocardial collagen volume fraction (CVF) was elevated in the hypertensive group but it also decreased after ablation, indicating that the level of cardiac remodeling was reduced. NE, Ang II, Ald and AVP in the hypertensive group were significantly higher (P<0.05) but NE and AVP decreased in hypertension+ablation group (P<0.05) after RSD. No significant difference was observed in Ald and Ang II. CONCLUSION RSD can reduce blood pressure caused by pressure-overload and can also reduce cardiac hypertrophy and cardiac fibrosis. The effects of RSD on long-term hypertension and cardiac remodeling may result from reducing the sympathetic ganglion of renal arteries.

参考文献/References

[1]Katholi RE,Rocha-Singh KJ,Goswami NJ,et al.Renal nerves in the maintenance of hypertension:a potential therapeutic target[J].CurrHypertens Rep,2010,12(3):196-204.
[2]Carretero OA,Scicli AG.Local hormonal factors (intracrine,autocrine,and paracrine)in hypertension[J].Hypertension,1991,18(3 Suppl):I58-I69.
[3]Vonend O,Marsalek P,Russ H,et al.Moxonidine treatment of hypertensive patients with advanced renal failure[J].J Hypertens,2003,21(9):1709-1717.
[4]Krum H,Schlaich M,Whitbourn R,et al.Catheter-based renal sympathetic denervation for resistant hypertension:a multicentre safetyand proof-of-principle cohort study[J].Lancet,2009,373(9671):1275-1281.
[5]DiBona GF,Esler M.Translational medicine:the antihypertensive effect of renal denervation[J].Am J PhysiolRegulIntegr Comp Physiol,2010,298(2):R245-253.
[6]闫丽辉,何昆仑,蔡毅,等.新西兰兔腹主动脉缩窄术后心肌收缩和舒张功能的变化[J].中华老年心脑血管病杂志,2007,19(6):404-406.
[7]Katholi RE,Rocha-Singh KJ.The role of renal sympathetic nerves in hypertension: has percutaneous renal denervation refocused attention on their clinical significance?[J].ProgCardiovasc Dis,2009,52(3):243-248.
[8]Frohlich ED.Renal denervation using an irrigated radiofrequency ablation catheter for management of drug-resistant hypertension:a demonstrated value?[J].JACC CardiovascInterv,2012,5(7):766-768.
[9]Parati G,Ochoa JE,Bilo G.Renal sympathetic denervation and daily life blood pressure in resistant hypertension:simplicity or complexity?[J].Circulation,2013,128(4):315-317.
[10]Versaci F,Trivisonno A,Olivieri C,et al.Is an abnormal vascular response after renal sympathetic denervation predictive of permanent damage? An unusual case of late renal artery stenosis after energy delivery[J].J EndovascTher,2014,21(2):191-196.
[11]Streitparth F,Walter A, Stolzenburg N,et al.MR-guided periarterial ethanol injection for renal sympathetic denervation:a feasibility study in pigs[J].CardiovascIntervent Radiol,2013,36(3):791-796.
[12]Lu J,Ling Z,Chen W,et al.Effects of renal sympathetic denervation using saline-irrigated radiofrequency ablation catheter on the activity of the renin-angiotensin system and endothelin-1[J].J Renin Angiotensin Aldosterone Syst,2014,15(4):532-539.
[13]van Vark LC,Bertrand M,Akkerhuis KM,et al.Angiotensin-converting enzyme inhibitors reduce mortality in hypertension:a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients[J].Eur Heart J,2012,33(16):2088-2097.
[14]Eppel GA,Luff SE,Denton KM,et al.Type 1 neuropeptide Y receptors and alpha1-adrenoceptors in the neural control of regional renal perfusion[J].Am J Physiol Regul Integr Comp Physiol,2006,290(2):R331-R340.
[15]Ciriello J,de Oliveira CV.Renal afferents and hypertension[J].Curr Hypertens Rep,2002,4(2):136-142.
[16]Kotchen TA.Obesity-related hypertension:epidemiology,pathophysiology, and clinical management[J].Am J Hypertens,2010,23(11):1170-1178.
[17]TSchlaich MP,Sobotka PA,Krum H,et al.Renal sympathetic-nerve ablation for uncontrolled hypertension[J].N Engl J Med,2009,361(9):932-934.

备注/Memo

备注/Memo:
收稿日期：2014-10-23.
基金项目：西安市医学攻关计划项目资助（SF1201）
通讯作者：郑强荪，主任医师，主要从事复杂快速心律失常的射频消融研究 Email：tdxznk01@fmmu.edu.cn
作者简介：于亮，主治医师，硕士生 Email：coolfisker@163.com
更新日期/Last Update: 2015-04-22